Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 536

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 536
---
arrants are liability-classified warrants and are recognized as liabilities (refer to Notes 1 and 4). During the year ended December 31, 2023, the SPAC Warrants held by Sorrento were repurchased, and certain of such warrants transferred to Oramed, as a result of the Sorrento SPA (refer to Note 8). On September 20, 2024, the Company repurchased 4,000,000of the SPAC Warrants , which are currently exercisable for an F-37 aggregate of up to 114,286shares of Common Stock,held by Oramed (refer to Note 7). Following the repurchase, these warrants were cancelled. As of December 31, 2024 and 2023, there were 5,467,692and 6,854,309Public Warrants outstanding, which are currently exercisable for an aggregate of up to 156,220shares of Common Stock and 195,838shares of Common Stock,respectively. As of December 31, 2024 and 2023, there were 1,000,000and 3,613,383Private Warrants outstanding, which are currently exercisable for an aggregate of up to 28,572shares of Common Stock and 103,240shares of Common Stock, respectively. Preferred Stock The Company is authorized to issue 45,000,000shares of preferred stock (the “Preferred Stock”) of which there are two series in total. Series A Preferred Stock As of December 31, 2024 and 2023, there were 29,057,097shares of Series A Preferred Stock outstanding. On September 21, 2023, the Series A Preferred Stock was repurchased and derecognized for accounting purposes. The Series A Preferred Stock is currently held as collateral for the Oramed Note. Series 1 Preferred Stock On October 27, 2024, the Board declared a stock dividend (the “Dividend”) consisting of an aggregate of 5,000,000shares (the “Dividend Stock”) of Series 1 Mandatory Exchangeable Preferred Stock, par value $ 0.0001per share (the “Series 1 Preferred Stock”), of the Company to record holders of certain of the Company’s securities as of the close of business on November 7, 2024 (which date was subsequently changed to such later date to be determined in the sole discretion of the Board).Pursuant to